Our LRRC15-RIT approach effectively targeted various cancer models, including models of breast cancer, osteosarcoma, glioblastoma, and colorectal cancer, all representing highly lethal cancers with distinct tumor biology and LRRC15 expression patterns. This evidence concerns the gene LRRC15 and osteosarcoma.